{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:54:44Z","timestamp":1791582884829,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011912","name":"School of Medicine, Washington University in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtho.2026.104201","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:41:16Z","timestamp":1789627276000},"page":"104201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genomic and Transcriptomic Features of Relapsed SCLC"],"prefix":"10.1016","author":[{"given":"Siddhartha","family":"Devarakonda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumithra","family":"Sankararaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zach L.","family":"Skidmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett H.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kymberlie","family":"Pepin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"McMichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Morgensztern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiama Naheed","family":"Waqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Brinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trudy G.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malachi","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obi L.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-9612","authenticated-orcid":false,"given":"Ramaswamy","family":"Govindan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2026.104201_bib1","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1200\/JCO.2005.04.4859","article-title":"Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database","volume":"24","author":"Govindan","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtho.2026.104201_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cllc.2023.01.012","article-title":"Current and emerging treatment options for patients with relapsed small-cell lung carcinoma: a systematic literature review","volume":"24","author":"Bernab\u00e9-Caro","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtho.2026.104201_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S2213-2600(22)00389-7","article-title":"Relapsed small-cell lung cancer: a disease of continued unmet need","volume":"11","author":"Rosner","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jtho.2026.104201_bib4","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jtho.2021.07.018","article-title":"Overcoming chemotherapy resistance in SCLC","volume":"16","author":"Herzog","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104201_bib5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccell.2017.01.006","article-title":"Chemosensitive relapse in small cell lung cancer proceeds through an EZH2-SLFN11 axis","volume":"31","author":"Gardner","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtho.2026.104201_bib6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ccell.2021.02.014","article-title":"Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress","volume":"39","author":"Thomas","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtho.2026.104201_bib7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1158\/2159-8290.CD-23-0656","article-title":"Acquired cross-resistance in small cell lung Cancer due to extrachromosomal DNA amplification of MYC paralogs","volume":"14","author":"Pal Choudhuri","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtho.2026.104201_bib8","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1038\/s41467-018-06162-9","article-title":"Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer","volume":"9","author":"Wagner","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtho.2026.104201_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jtho.2026.104201_bib10","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ng.2405","article-title":"Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer","volume":"44","author":"Rudin","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtho.2026.104201_bib11","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41586-024-07177-7","article-title":"Evolutionary trajectories of small cell lung cancer under therapy","volume":"627","author":"George","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jtho.2026.104201_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg1850","article-title":"YAP drives fate conversion and chemoresistance of small cell lung cancer","volume":"7","author":"Wu","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jtho.2026.104201_bib13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s43018-019-0020-z","article-title":"Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer","volume":"1","author":"Stewart","year":"2020","journal-title":"Nat Cancer"},{"key":"10.1016\/j.jtho.2026.104201_bib14","first-page":"15.11.1","article-title":"Using FunSeq2 for coding and non-coding variant annotation and prioritization","volume":"57","author":"Dhingra","year":"2017","journal-title":"Curr Protoc Bioinformatics"},{"key":"10.1016\/j.jtho.2026.104201_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2020.08.006","article-title":"Distinct classes of complex structural variation uncovered across thousands of cancer genome graphs","volume":"183","author":"Hadi","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jtho.2026.104201_bib16","first-page":"5264","article-title":"CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas","volume":"52","author":"Jackson","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2026.104201_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jtho.2026.104201_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","article-title":"Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data","volume":"19","author":"Rudin","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jtho.2026.104201_bib19","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","article-title":"WNT\/\u03b2-catenin pathway activation correlates with immune exclusion across human cancers","volume":"25","author":"Luke","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2026.104201_bib20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/2326-6066.CIR-16-0400","article-title":"Constitutive IDO1 expression in human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance","volume":"5","author":"Hennequart","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jtho.2026.104201_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111704","article-title":"MYC regulates a pan-cancer network of co-expressed oncogenic splicing factors","volume":"41","author":"Urbanski","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jtho.2026.104201_bib22","doi-asserted-by":"crossref","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","article-title":"rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data","volume":"111","author":"Shen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtho.2026.104201_bib23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2017.08.018","article-title":"Coordinated splicing of regulatory detained introns within oncogenic transcripts creates an exploitable vulnerability in malignant glioma","volume":"32","author":"Braun","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtho.2026.104201_bib24","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtho.2026.104201_bib25","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1158\/2159-8290.CD-20-0913","article-title":"Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity","volume":"11","author":"Mahadevan","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtho.2026.104201_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"10.1016\/j.jtho.2026.104201_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2026.103726","article-title":"Antibody-drug conjugates in SCLC: DLL3, B7-H3, TROP2, and beyond","volume":"21","author":"Monaca","year":"2026","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104201_bib28","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41388-020-01583-7","article-title":"Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-\u03baB","volume":"40","author":"Periyasamy","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.jtho.2026.104201_bib29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ccr.2013.04.025","article-title":"Chromoplexy: a new category of complex rearrangements in the cancer genome","volume":"23","author":"Shen","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtho.2026.104201_bib30","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41556-022-00913-z","article-title":"Pan-cancer pervasive upregulation of 3\u2032 UTR splicing drives tumourigenesis","volume":"24","author":"Chan","year":"2022","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jtho.2026.104201_bib31","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.yexcr.2006.03.029","article-title":"AU-rich elements and alternative splicing in the beta-catenin 3\u2019UTR can influence the human beta-catenin mRNA stability","volume":"312","author":"Thiele","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jtho.2026.104201_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96167-0","article-title":"Intrinsic activation of \u03b2-catenin signaling by CRISPR\/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma","volume":"11","author":"Akasu","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtho.2026.104201_bib33","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.1073\/pnas.142298299","article-title":"Characterization of the expression of MHC proteins in human embryonic stem cells","volume":"99","author":"Drukker","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtho.2026.104201_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.jtho.2026.104201_bib35","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1158\/1078-0432.CCR-19-2095","article-title":"The NKG2A-HLA-E axis as a novel checkpoint in the tumor microenvironment","volume":"26","author":"Borst","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2026.104201_bib36","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jtho.2020.05.008","article-title":"Harnessing natural killer immunity in metastatic SCLC","volume":"15","author":"Best","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104201_bib37","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS8129","article-title":"A phase II trial of monalizumab in combination with durvalumab (MEDI4736) plus platinum-based chemotherapy for first-line treatment of extensive stage small cell lung cancer (MOZART): Hoosier Cancer Research Network LUN21-530 study","volume":"42","author":"Mamdani","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtho.2026.104201_bib38","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1158\/2159-8290.CD-20-0555","article-title":"Splicing patterns in SF3B1-mutated uveal melanoma generate shared immunogenic tumor-specific neoepitopes","volume":"11","author":"Bigot","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtho.2026.104201_bib39","article-title":"Bright side of the dark genome: antigens for next-gen cancer vaccines","volume":"14","author":"Wang","year":"2026","journal-title":"J Immunother Cancer"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086426006544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086426006544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:14:50Z","timestamp":1791580490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086426006544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":39,"alternative-id":["S1556086426006544"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2026.104201","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic and Transcriptomic Features of Relapsed SCLC","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2026.104201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"104201"}}